E-LIB Suche - Ergebnisse für: Morozova, T E

1

Effect of genetic polymorphisms and haplotypes on the effic..:

Shatskiy, D A ; Morozova, T E ; Shikh, N V...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

2

Combined antihypertensive therapy in the light of modern re..:

Morozova, T E
Systemic Hypertension. 15 (2018) 4 - p. 92-96 , 2018

Link: https://doi.org/10.26442..

3

Retrospective View on Clinical Aspects and Treatment of Nos..:

Chukina, M.A. ; Lukina, M.V. ; Tsarev, I.L...
Clinical Therapeutics. 39 (2017) 8 - p. e62-e63 , 2017

Link: https://doi.org/10.1016/..

4

Sepsis Biomarker Prognostic Significance—Presepsin Role In ..:

Lukina, M.V. ; Chukina, M.A. ; Andruschishina, T.B..
Clinical Therapeutics. 39 (2017) 8 - p. e32-e33 , 2017

Link: https://doi.org/10.1016/..

5

Gene Polymorphism C3435T For ABCB1 and Antihypertensive Eff..:

Sychev, D.A. ; Shih, N.V. ; Grishina, E.A...
Clinical Therapeutics. 39 (2017) 8 - p. e30-e31 , 2017

Link: https://doi.org/10.1016/..

6

Risk Factors for Acute Kidney Injury In Cardiac Surgical Pa..:

Lukina, M.V. ; Chukina, M.A. ; Andruchichina, T.B..
Clinical Therapeutics. 39 (2017) 8 - p. e30 , 2017

Link: https://doi.org/10.1016/..

7

Combined pharmacotherapy of arterial hypertension. Overview..:

Morozova, T E ; Andrushchishina, T B ; Yudina, I Yu
Systemic Hypertension. 13 (2016) 3 - p. 58-63 , 2016

Link: https://doi.org/10.26442..

8

Fixed dose combinations for the treatment arterial hyperten..:

Morozova, T E ; Andreev, S S
Systemic Hypertension. 12 (2015) 3 - p. 25-29 , 2015

Link: https://doi.org/10.26442..

9

Possibilities ARB II (sartans) in hypertensive patients:

Morozova, T E ; Andrushchishina, T B ; Gontarenko, S V
Systemic Hypertension. 11 (2014) 3 - p. 33-38 , 2014

Link: https://doi.org/10.26442..

10

Inertness criterion for gas-chromatographic systems:

Zenkevich, I. G. ; Morozova, T. E. ; Klark-Karskaya, Yu. F.
Journal of Analytical Chemistry. 69 (2014) 12 - p. 1130-1140 , 2014

Link: https://doi.org/10.1134/..

11

Areas of application and characteristics of quantitative ch..:

Zenkevich, I. G. ; Morozova, T. E.
Journal of Analytical Chemistry. 69 (2014) 4 - p. 327-335 , 2014

Link: https://doi.org/10.1134/..

12

Chronic obstructive pulmonary disease combined with arteria..:

Ovcharenko, S I ; Nersesyan, Z N ; Morozova, T E
Systemic Hypertension. 11 (2014) 2 - p. 54-58 , 2014

Link: https://doi.org/10.26442..

13

Statins in the treatment and the prevention of the progress..:

Morozova, T. E ; Vartanova, O. A
CardioSomatics. 4 (2013) 1 - p. 28-35 , 2013

Link: https://doi.org/10.26442..

14

Sartans in the treatment of high-risk hypertension: the abi..:

Morozova, T E
Systemic Hypertension. 10 (2013) 2 - p. 13-18 , 2013

Link: https://doi.org/10.26442..

15

Rational pharmacotherapy of hypertension. Urapidil potentia:

Morozova, T E ; Andruschishina, T B ; Shmarova, D G
Systemic Hypertension. 10 (2013) 4 - p. 38-43 , 2013

Link: https://doi.org/10.26442..